LMR Partners »

Terns Pharmaceuticals shares owned by LMR Partners

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by LMR Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $167k 20k 8.34
2023-03-31 $188k 16k 11.84

More positions owned by LMR Partners

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Put Option (NVDA)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Microstrategy Cl A New (MSTR)
Advanced Micro Devices Put Option (AMD)
Capri Holdings SHS Call Option (CPRI)
Tesla Motors (TSLA)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Endeavor Group Hldgs Cl A Com (EDR)
Microsoft Corporation (MSFT)
Moderna (MRNA)
Albertsons Cos Common Stock Call Option (ACI)
Dish Network Corporation Note 3.375% 8/1 (Principal)

View all positions for LMR Partners

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Deep Track Capital
Soleus Capital Management
BlackRock
BlackRock
Citadel Advisors
VR Adviser
Schonfeld Strategic Advisors
Point72 Asset Management
Vanguard Group
Avidity Partners Management
Driehaus Capital Management
ExodusPoint Capital Management
T. Rowe Price Associates
Geode Capital Management

View all funds holding Terns Pharmaceuticals